Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00164333 · ClinicalTrials.gov registry record · Phase 2
The Treatment Advocacy Program
A Phase 2 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
NCT00164333 is a Phase 2 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 300 participants.
The verdict
NCT00164333, a Phase 2 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of the study is to test the efficacy of TAP, a behavioral intervention, in improving sexual safety and treatment adherence among gay and bisexual men infected with HIV. It is hypothesized that those who are in the intervention group will report reductions in unprotected sex with HIV-negative and unknown-status partners; and will show stricter adherence to their treatment regimens, compared to the individuals in the standard-of-care, control group.
Interventions
- BEHAVIORAL TAP: Treatment Advocacy Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2004-09 |
| Est. Completion | 2008-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00164333
The ClinicalTrials.gov registry entry for NCT00164333 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TAP: Treatment Advocacy Program is the first listed.
NCT00164333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00164333 about?
NCT00164333 is a clinical study titled "The Treatment Advocacy Program". The purpose of the study is to test the efficacy of TAP, a behavioral intervention, in improving sexual safety and treatment adherence among gay and bisexual men infected with HIV. It is hypothesized that those who are in the intervention group will report reductions in unprotected sex with HIV-nega...
What is the current status of trial NCT00164333?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2004-09. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00164333?
The interventions under investigation include: TAP: Treatment Advocacy Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00164333?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.